Patents by Inventor Dana HAYOUN NEEMAN

Dana HAYOUN NEEMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF GENERATING OLIGODENDROCYTE PROGENITOR CELLS AND USE THEREOF
    Publication number: 20240158745
    Abstract: Methods for differentiating human pluripotent stem cells to oligodendrocyte progenitor cells (OPCs) are provided. Also provided are cells and cellular compositions obtained by such methods, and uses of such cells. Further provided are methods and protocols for efficiently differentiating human pluripotent stem cells to OPCs.
    Type: Application
    Filed: March 10, 2022
    Publication date: May 16, 2024
    Inventors: Rami SKALITER, Francois BINETTE, Dana HAYOUN NEEMAN, Assaf BAHAT, Ofer WISER
  • COMPOSITIONS AND METHODS FOR EMBRYONIC STEM CELL EXPANSION
    Publication number: 20230313127
    Abstract: Provided herein are methods and compositions for expansion of human embryonic stem with suspendable expansion complexes including microcarriers.
    Type: Application
    Filed: August 10, 2021
    Publication date: October 5, 2023
    Inventors: Lilach ALON, Rami SKALITER, Ravid TIKOTZKI, Dana HAYOUN NEEMAN, Ofer WISER
  • RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
    Publication number: 20230119816
    Abstract: Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therapy compositions for cryopreservation and administration of the cryopreserved composition to a subject subsequent to thawing are also presented. In another aspect, the RTA composition may be formulated as a thaw and inject (TAI) composition, whereby the composition is administered by injection subsequent to thawing.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 20, 2023
    Inventors: Nir Netzer, Ofer Wiser, Bat Shahaf, Orit Gamburg, Lior Rosenberg Belmaker, Dana Hayoun Neeman, Osnat Bohana Kashtan
  • RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
    Publication number: 20220408719
    Abstract: Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therapy compositions for cryopreservation and administration of the cryopreserved composition to a subject subsequent to thawing are also presented. In another aspect, the RTA composition may be formulated as a thaw and inject (TAI) composition, whereby the composition is administered by injection subsequent to thawing.
    Type: Application
    Filed: August 23, 2022
    Publication date: December 29, 2022
    Inventors: Nir Netzer, Ofer Wiser, Bat Shahaf, Orit Gamburg, Lior Rosenberg Belmaker, Dana Hayoun Neeman, Osnat Bohana Kashtan
  • RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
    Publication number: 20220095608
    Abstract: Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therapy compositions for cryopreservation and administration of the cryopreserved composition to a subject subsequent to thawing are also presented. In another aspect, the RTA composition may be formulated as a thaw and inject (TAI) composition, whereby the composition is administered by injection subsequent to thawing.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Nir NETZER, Ofer WISER, Bat SHAHAF, Orit GAMBURG, Lior ROSENBERG BELMAKER, Dana HAYOUN NEEMAN, Osnat BOHANA KASHTAN
  • RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
    Publication number: 20210000102
    Abstract: Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therapy compositions for cryopreservation and administration of the cryopreserved composition to a subject subsequent to thawing are also presented. In another aspect, the RTA composition may be formulated as a thaw and inject (TAI) composition, whereby the composition is administered by injection subsequent to thawing.
    Type: Application
    Filed: December 28, 2018
    Publication date: January 7, 2021
    Applicant: Cell Cure Neurosciences Ltd.
    Inventors: Nir NETZER, Ofer WISER, Bat SHAHAF, Orit GAMBURG, Lior ROSENBERG BELMAKER, Dana HAYOUN NEEMAN, Osnat BOHANA KASHTAN